
Summary:
Verastem Oncology is seeking an Executive Director, Patient Services to lead U.S. patient services and field reimbursement for its current and future portfolio.This leader owns the strategy, design and performance of Verastem’s patient support programs, including Verastem Cares, hub services and affordability programs, while building the patient services model for the VS-7375 launch. The role reports to the Vice President, Market Access, and will build and lead the Patient Services organization, including field teams supporting current and future products. This leadership role requires a professional with demonstrated experience designing and managing oncology patient support programs, deep knowledge of the hub, specialty pharmacy and affordability landscape, a track record of leading field-based teams, and the ability to operate effectively at both strategic and operational levels.
Operations, compliance and team
Capabilities

Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with RAS/MAPK pathway-driven cancers. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition, FAK inhibition and KRAS G12D inhibition.
Pursuing unexplored pathways demands that we’re purposeful in everything we do. And it’s an endeavor that’s only possible with an experienced team of employees and partners dedicated to a singular purpose: changing and improving the way cancer is treated by delivering novel therapies that address areas of high unmet need in RAS/MAPK pathway-driven cancers. At Verastem Oncology, it takes our diversity of backgrounds, expertise, perspectives, and skills to find the answers that patients need, but don’t have—yet. To join our team or for more information, please visit www.verastem.com.
X/Twitter: @VerastemOncolog